[Commentary on] Clinical evidence for topotecan-paclitaxel non-cross resistance in ovarian cancer Journal Article
| Author: | Sabbatini, P. |
| Article Title: | [Commentary on] Clinical evidence for topotecan-paclitaxel non-cross resistance in ovarian cancer |
| Keywords: | time factors; disease progression; drug interactions; ovarian neoplasms -- drug therapy; paclitaxel -- therapeutic use; female |
| Journal Title: | Women's Oncology Review |
| Volume: | 1 |
| Issue: | 2 |
| ISSN: | 1473-3404 |
| Publisher: | Taylor & Francis Group |
| Date Published: | 2001-06-01 |
| Start Page: | 171 |
| End Page: | 172 |
| Language: | English |
| ACCESSION: | 2004131909 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| DOI/URL: | |
| Notes: | Accession Number: 2004131909 -- Entry Date: 20040806 -- Revision Date: 20090313 -- Publication Type: journal article; abstract; commentary -- Original Study: Gore M, ten Bokkel Huinink WM, Carmichael J, Gordon A, Davidson N, Coleman R et al -- Clinical evidence for topotecan-paclitaxel non-cross resistance in ovarian cancer -- J CLIN ONCOL 2001; 19: 1893-900 -- Journal Subset: Biomedical; Editorial Board Reviewed; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 101128014. -- Source: cin20 |
MSK Authors
-
262Sabbatini